SIA FUNDS, EL FONDO QUE CONFÍA EN GRÍFOLS SE POSICIONA EN CONTRA DE LA OPA .: Zepsyre ( Lurbinectedin ) More Pronounced in Overall Survival | OS Endpoint is Preferable from Regulatory POV . By Pascal Besman Chief Operating Officer of PharmaMar .